Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Clinical trial NCT02663297 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02663297
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Disease Lymphoma Lymphoma, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type

Start date: 2016-06-07
Primary completion: 2021-01-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.